3M Company (Minnesota Mining and Manufacturing Company) - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for the period ended June 30, 2000. 3M is a diversified technology company operating in over 60 countries. The report covers the second quarter and the first six months of fiscal year 2000, comparing results to the same periods in 1999. The financial statements are unaudited but reviewed by PricewaterhouseCoopers LLP.
Key Financial Metrics
| Metric (in millions) | Q2 2000 | Q2 1999 | 6 Months 2000 | 6 Months 1999 |
|---|---|---|---|---|
| Net Sales | $4,224 | $3,863 | $8,276 | $7,639 |
| Operating Income | $777 | $804 | $1,592 | $1,453 |
| Net Income | $470 | $476 | $957 | $860 |
| Diluted EPS | $1.18 | $1.17 | $2.39 | $2.12 |
| Operating Margin | 18.4% | 20.8%* | 19.2% | 19.0%* |
| Cash from Operations (6mo) | $1,153 (2000) vs $1,713 (1999) | |||
| Total Debt | $3,064 (Short-term: $1,871; Long-term: $1,193) | |||
| Cash & Equivalents | $420 |
*Note: Q2 1999 operating margin calculation excludes a $104 million non-recurring gain on divestitures included in reported figures.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.3% in Q2 and 8.3% for the six months ended June 30, 2000. Growth was driven by an 11-12% increase in volume, partially offset by a ~2% decline in selling prices (notably in electronics) and a ~1% negative impact from currency fluctuations.
- Profitability: While reported operating income decreased slightly in Q2 ($777M vs $804M), this comparison is skewed by a $104 million non-recurring gain in Q2 1999 from divestitures. Excluding non-recurring items, operating income improved to 18.4% of sales in Q2 2000, up from 18.1% in Q2 1999.
- Acquisitions: In Q2 2000, 3M acquired 81% of Quante AG (telecommunications) and four smaller businesses for $297 million in cash plus stock. This contributed to sales growth in the Electro and Communications segment.
- Cost Structure: Cost of goods sold as a percentage of sales decreased to 56.3% in Q2 2000 from 56.6% in Q2 1999, aided by productivity gains and lower employee benefit costs, despite higher raw material costs.
- Cash Flow: Net cash provided by operating activities decreased to $1.153 billion for the first six months of 2000 from $1.713 billion in 2000, primarily due to increased accounts receivable and inventory levels supporting sales growth.
Guidance, Outlook, and Risks
- Outlook: Management expects sales to increase approximately 10% in local currencies for the remainder of 2000, including the impact of the Quante AG acquisition. Currency is expected to reduce full-year 2000 sales by about 1.5% and earnings by approximately 13 cents per share due to a weaker Euro.
- Cost Expectations: Raw material costs are projected to increase about 2% for the full year 2000.
- Product Phase-Out: In May 2000, 3M announced a plan to substantially phase out production of perfluorooctanyl chemistry (used in Scotchgard and other products) by the end of 2000. This affects approximately $300 million in annual sales. No charges were recorded in Q2 2000 as accounting requirements for severance were not yet met, and equipment impairment was not deemed necessary.
- Legal Contingencies:
- Breast Implant Litigation: 3M is a defendant in 2,102 lawsuits involving 7,648 claimants. The company has accrued $48 million in liabilities (after $1.152 billion in payments) and holds $554 million in receivables for insurance recoveries. A jury verdict in February 2000 was favorable to 3M regarding insurance coverage, with a final judgment expected in Q3 2000.
- Environmental Matters: The company faces potential liabilities for remediation at numerous sites. While current accruals are deemed adequate, future costs could exceed estimates due to regulatory changes or new information.
- Accounting Pronouncements: The company is reviewing the impact of SFAS No. 133 (Derivatives) and SAB 101 (Revenue Recognition), with adoption dates in late 2000 or 2001.
Investor Verification Checklist
- Non-Recurring Items: Verify the impact of the $104 million divestiture gain in Q2 1999 and the $50 million distribution agreement termination gain in Q1 2000 when comparing operating income trends.
- Currency Impact: Assess the sensitivity of future earnings to the strengthening U.S. dollar, which management estimates will reduce full-year earnings by 13 cents per share.
- Implant Litigation Resolution: Monitor the final court judgment regarding insurance coverage for breast implant liabilities expected in Q3 2000 and the timing of insurance recoveries.
- Phase-Out Costs: Watch for potential charges related to the phase-out of perfluorooctanyl chemistry in the second half of 2000, specifically regarding severance or equipment impairment.
- Acquisition Integration: Evaluate the performance of the newly acquired Quante AG and its contribution to the Electro and Communications segment growth.